GTF3C4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.46278561380586E-12 |
Normal-vs-Stage2 |
3.3744118610457E-12 |
Normal-vs-Stage3 |
1.62458935193399E-12 |
Normal-vs-Stage4 |
1.62714286489063E-12 |
Stage1-vs-Stage2 |
5.439800E-02 |
Stage1-vs-Stage3 |
2.13669999999944E-05 |
Stage1-vs-Stage4 |
1.961410E-04 |
Stage2-vs-Stage3 |
2.138400E-01 |
Stage2-vs-Stage4 |
2.327600E-01 |
Stage3-vs-Stage4 |
8.854800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62458935193399E-12 |
Normal-vs-AfricanAmerican |
5.13790121559055E-11 |
Normal-vs-Asian |
9.287600E-02 |
Caucasian-vs-AfricanAmerican |
3.542400E-01 |
Caucasian-vs-Asian |
1.545820E-01 |
AfricanAmerican-vs-Asian |
8.831900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62447832963153E-12 |
Normal-vs-Female |
1.05080388834722E-11 |
Male-vs-Female |
1.980680E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.44539999968885E-07 |
Normal-vs-Age(41-60Yrs) |
1.64057656348859E-12 |
Normal-vs-Age(61-80Yrs) |
<1E-12 |
Normal-vs-Age(81-100Yrs) |
1.02939999857554E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.391800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.019000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.070800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.831900E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.837200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.484400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.728500E-02 |
Normal-vs-Grade 2 |
4.18465262441714E-12 |
Normal-vs-Grade 3 |
<1E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
1.317600E-01 |
Grade 1-vs-Grade 3 |
6.155900E-03 |
Grade 1-vs-Grade 4 |
4.638600E-04 |
Grade 2-vs-Grade 3 |
8.646700E-04 |
Grade 2-vs-Grade 4 |
4.69169999994801E-06 |
Grade 3-vs-Grade 4 |
3.336400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.09099995493756E-09 |
Normal-vs-ccB subtype |
1.62436730732907E-12 |
ccA subtype-vs-ccB subtype |
1.33960000003874E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62458935193399E-12 |
Normal-vs-N1 |
5.664200E-03 |
N0-vs-N1 |
8.830600E-01 |
|
|